Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
ID: 340229Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/340229

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) grant. This initiative aims to support studies that identify, develop, and test strategies to overcome barriers to the adoption and sustainability of evidence-based health interventions, with a particular emphasis on promoting equitable dissemination among underrepresented communities. The program encourages innovative research designs and collaborations across multi-disciplinary teams to enhance public health outcomes, with a funding ceiling of $275,000 available for a maximum duration of two years. Applications are accepted until May 8, 2025, and interested parties can find more information and submit their proposals through Grants.gov. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-109-Full-Announcement.html
    PAR-22-109.html
    The Department of Health and Human Services has issued a Funding Opportunity Announcement (FOA) to support Dissemination and Implementation Research in Health, spearheaded by several National Institutes of Health (NIH) components. This FOA aims to identify, develop, and assess strategies overcoming barriers to the integration and sustainability of evidence-based health interventions. Priority is given to studies that promote equitable dissemination among underrepresented communities and methods for de-implementing ineffective practices. The FOA encourages innovative research designs, comprehensive collaborations across multi-disciplinary teams, and robust stakeholder engagement to enhance public health and improve health outcomes. It also includes specific interests from participating NIH institutes, such as the NCI’s focus on cancer control and health equity. The funding is structured under R21 Exploratory/Developmental Research Grants, with total direct costs not exceeding $275,000 for a maximum of two years, and applications are accepted until May 8, 2025. Registration in the System for Award Management and submission via Grants.gov are mandatory for applicants. The initiative highlights the necessity of translating scientific discoveries into practical applications that improve healthcare delivery and address systemic disparities.
    Similar Opportunities
    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" aimed at supporting research that addresses barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages studies that promote equitable dissemination among underrepresented communities and explore the de-implementation of ineffective practices, emphasizing the importance of interdisciplinary collaboration and stakeholder engagement. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and government organizations, with funding amounts determined by NIH appropriations and the quality of applications. The application deadline is May 7, 2025, and interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) grant, aimed at supporting studies that identify and test strategies to enhance the adoption and sustainability of evidence-based health interventions, particularly in underrepresented communities. The initiative focuses on overcoming barriers to the integration of these practices in healthcare settings while promoting equity in health outcomes, encouraging research that addresses both the effectiveness of health interventions and the dissemination strategies necessary for broad implementation. Eligible organizations include higher education institutions, nonprofits, and local governments, with grants of up to $50,000 per year available for a maximum of two years. Interested applicants must submit their proposals by May 7, 2025, and can find additional information and application instructions at http://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html, or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Early-Stage Dissemination and Implementation Research in Communication Disorders" under the R21 grant mechanism. This initiative aims to support early-stage research projects that enhance the dissemination and implementation of evidence-based innovations (EBIs) in areas such as hearing, speech, balance, taste, and language, with a focus on addressing barriers to adoption in clinical settings. The funding opportunity will provide approximately $1 million, with individual project budgets capped at $275,000 over a two-year period, and applications are due by October 12, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support innovative research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations, with a focus on mechanistic studies and the development of new methodologies. The program is designed to foster collaboration among scientists and build a nationwide cohort dedicated to advancing the understanding of cancer disparities, ultimately leading to future R01 projects. Applications can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years, and the closing date for submissions is November 16, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) to support innovative research projects at the preliminary or conceptual stage, particularly those with the potential to advance biomedical, behavioral, or clinical research. Applicants must include at least one clinical trial in their proposals, focusing on mechanistic studies that align with the scientific missions of participating NIH Institutes and Centers. This funding opportunity is crucial for stimulating novel research that challenges conventional methods and improves clinical practices, with a maximum budget of $275,000 available for a two-year project, and no more than $200,000 allocated in any single year. Interested applicants should adhere to strict submission guidelines and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance; the application deadline is January 7, 2025.
    NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional grant for exploratory and developmental research projects aimed at optimizing health and advancing health equity. This initiative encourages applicants to propose innovative research that aligns with the NINR Strategic Plan (2022-2026) and employs nursing's holistic approach to address critical health challenges while fostering diversity and inclusion through a required Plan for Enhancing Diverse Perspectives (PEDP). Eligible organizations include higher education institutions, nonprofits, and local governments, with a budget limit of $275,000 over two years. Interested applicants should note that the application deadline is May 7, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-22-231.html for further details.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.